| Bioactivity | Type II TRK inhibitor 1 is a potent TRK inhibitor, which inhibits various TRK fusion protein variants and wild type. Type II TRK inhibitor 1 exhibits antiproliferative activity against Ba/F3 cells harboring CD74-TRKAG667C and ETV6-TRKCG696C fusion proteins with IC50s of 6 nM and 1.7 nM, respectively[1]. |
| Invitro | Type II TRK inhibitor 1 (compound 7b) (3.1-800 nM; 2 h) 抑制 TRKA,PLCγ1 和 ERK 的磷酸化[1]。 Western Blot Analysis[1] Cell Line: |
| Name | Type II TRK inhibitor 1 |
| Formula | C35H33F3N8O3 |
| Molar Mass | 670.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang Z, et al. Discovery of the First Highly Selective and Broadly Effective Macrocycle-Based Type II TRK Inhibitors that Overcome Clinically Acquired Resistance. J Med Chem. 2022 Apr 28;65(8):6325-6337. |